Jean Costentin, MD

Affiliations: 
laboratoire de neuropsychopharmacologie expérimentale Université de Rouen 
Google:
"Jean Costentin"
Mean distance: 18.05 (cluster 11)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pelloux Y, Costentin J, Duterte-Boucher D. (2015) Differential involvement of anxiety and novelty preference levels on oral ethanol consumption in rats. Psychopharmacology. 232: 2711-21
Devos D, Lejeune S, Cormier-Dequaire F, et al. (2014) Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease. Parkinsonism & Related Disorders. 20: 170-5
Le Maître E, Dourmap N, Vilpoux C, et al. (2013) Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin. Brain Research. 1520: 51-60
Neveu C, Lefranc B, Tasseau O, et al. (2012) Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-β3-pseudopeptide agonist. Journal of Medicinal Chemistry. 55: 7516-24
Billet F, Costentin J, Dourmap N. (2012) Influence of corticostriatal δ-opioid receptors on abnormal involuntary movements induced by L-DOPA in hemiparkinsonian rats. Experimental Neurology. 236: 339-50
Stein AC, Viana AF, Müller LG, et al. (2012) Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs. Behavioural Brain Research. 228: 66-73
Cravezic A, Fichna J, Gach K, et al. (2011) Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice. Neuropharmacology. 61: 1229-38
Le Marec O, Neveu C, Lefranc B, et al. (2011) Structure-activity relationships of a series of analogues of the RFamide-related peptide 26RFa. Journal of Medicinal Chemistry. 54: 4806-14
Corvol JC, Bonnet C, Charbonnier-Beaupel F, et al. (2011) The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial. Annals of Neurology. 69: 111-8
Maltête D, Cottard AM, Mihout B, et al. (2011) Erythrocytes catechol-o-methyl transferase activity is up-regulated after a 3-month treatment by entacapone in parkinsonian patients. Clinical Neuropharmacology. 34: 21-3
See more...